Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.

about

Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.

Item

http://www.wikidata.org/entity/Q42383604

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@en

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@nl

type

Item

label

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@en

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@nl

prefLabel

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@en

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@nl

P1476

Interphase Molecular Cytogenet ...... n Blood or Bone Marrow Smears.

@en

P2093

Anita Glaser

http://www.w3.org/2001/XMLSchema#string

Beate Pohle

http://www.w3.org/2001/XMLSchema#string

Cordula Schlie

http://www.w3.org/2001/XMLSchema#string

Eyad Alhourani

http://www.w3.org/2001/XMLSchema#string

Rouben Aroutiounian

http://www.w3.org/2001/XMLSchema#string

Thomas Liehr

http://www.w3.org/2001/XMLSchema#string

Tigran Harutyunyan

http://www.w3.org/2001/XMLSchema#string

P2860

Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Clinical implications of the molecular genetics of chronic lymphocytic leukemia

Genomic aberrations and survival in chronic lymphocytic leukemia

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.

Chronic lymphocytic leukaemia: the nature of the leukaemic cell.

A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia

Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go

Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH)

De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience

P304

495-501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1369/0022155416655086

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27315825

http://www.w3.org/2001/XMLSchema#string

P932

4971778

http://www.w3.org/2001/XMLSchema#string